DILI, 14 january 2022 (TATOLI) – The National Hospital Guido Valadares (HNGV) collected more than US$ 63.793.52 from offering medical treatment to the 1.447 foreign nationals from january to december 2021.
Director of the Administration, Finance, and Logistic (AFL) of the HNGV, Raul Humberto Gama said that the cost for the medical treatment of the foreigners begins with the registration cost of US$5.00.
He said the medical treatment cost is varied among the diseases: “I can’t give you the details about the treatment of different diseases. But, I can say that the cost of the treatment depends on the level of the diseases and its treatment process.”
“The treatment for the foreign nationals may cost up to US$500, such as surgery. In addition, they need to pay for staying at the VIP rooms,” Gama told TATOLI at the HNGV, in Dili, on thursday.
He said unlike Timorese patients, the foreigners need to purchase the medicines when seeking medical treatment at the HNGV.
Gama said, in 2021, Guido Valadares National Hospital (HNGV) generated more than US$238.989,82 of operating revenue to the State’s coffer from january to december 2021. This revenue is made up of the cost of provision of medical treatment to local patients and foreign nationals.
Of the US$238.989,82, a total of US$28.731,50 came from the medical certificate department, US$845.00 from the Yellow Fever Vaccine, US$3.712.50 from Rooms Renting of Eye Treatment Unit, US$3.385.00 came from Eye Treatment Unit, US$834.00 came from Pediatric Unit, US$1.500.00 came from Colonoscopy, US$6.950.00 from Operation Block, US$24.183.50 from Radiography, US$3.010.00 from Ambulatory Services, US$3.803.50 from Maternity Unit, US$5.063.60 from Blood Bank, US$ 106.971.25 from VIP rooms, US$500.00 came from Physiotherapy, US$20.00 came from Odontology, US$1.830.85 came from Internal medicine, US$42.108.57 came from Medical Check-Up Unit, US$406.50 from Postpartum, US$25.00 from Heart Disease Treatment, US$589.00 from Chirurgical Unit, US$3.600.00 from Mortuary Unit, US$430.05 from BEDA, US$450.00 came from Hemodelisa, US$40.00 came from the Control of Acute Respiratory Infections (CARI).
Journalist: Filomeno Martins
Editor: Nelia Borges Rosario
